Veinplicity: coming soon to a hospital near you

Physeon has secured its first distribution agreement: Stephen Bailey, Managing Director of LINC Medical (Leicester, UK) and Yves Maag, Managing Director of Physeon (Schaffhausen, Switzerland) entered an agreement to launch Veinplicity in the UK and Ireland.

With that, Veinplicity will be available to hospitals, clinics and other medical professionals in this market as of September 1, 2016.

Veinplicity is an electrostimulation device that uses a specific wave form and frequency to make veins larger and stiffer enabling easer venous access especially in difficult-to-stick patients. A Class IIa medical device in the EU, we are currently in the registration process in Canada, Australia and the United States.

LINC Medical Systems Ltd is an established supplier of medical equipment and devices to UK healthcare providers and operates from a convenient central base in Leicester.

Physeon is excited to improve the lives of patients in the UK and Ireland. If you are interesting in becoming a distributor in your country, please do not hesitate to contact us at info@physeon.com.

LINC Medical, Physeon

#Distributors #Veinplicity #venousaccess

NEWSROOM

The Veinplicity device is CE marked and registered as a Class IIa medical device in the European Union and as a Class II medical device in Canada. We are seeking FDA approval. The device is manufactured within the ISO 13485 standard in the United States.

Featured Posts
Follow Veinplicity
Archive
Categories